Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20405124rdf:typepubmed:Citationlld:pubmed
pubmed-article:20405124lifeskim:mentionsumls-concept:C1003714lld:lifeskim
pubmed-article:20405124lifeskim:mentionsumls-concept:C0031921lld:lifeskim
pubmed-article:20405124lifeskim:mentionsumls-concept:C0580797lld:lifeskim
pubmed-article:20405124lifeskim:mentionsumls-concept:C0020205lld:lifeskim
pubmed-article:20405124lifeskim:mentionsumls-concept:C0042210lld:lifeskim
pubmed-article:20405124lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:20405124lifeskim:mentionsumls-concept:C1424969lld:lifeskim
pubmed-article:20405124lifeskim:mentionsumls-concept:C0872192lld:lifeskim
pubmed-article:20405124lifeskim:mentionsumls-concept:C1527177lld:lifeskim
pubmed-article:20405124lifeskim:mentionsumls-concept:C0441513lld:lifeskim
pubmed-article:20405124lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:20405124lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:20405124pubmed:issue4lld:pubmed
pubmed-article:20405124pubmed:dateCreated2010-6-28lld:pubmed
pubmed-article:20405124pubmed:abstractTextEnterotoxigenic Escherichia coli (ETEC) are an important cause of diarrheal morbidity in developing countries, especially in children and also of traveler's diarrhea. Colonization factors (CFs) of ETEC, like CFA/I and CS2 which are genetically and structurally related, play a substantial role in pathogenicity, and since intestinal-mucosal immune responses against CFs appear to be protective, much effort has focused on the development of a CF-based ETEC vaccine. We have constructed hybrid operons in which the major CS2 subunit-encoding cotA gene was inserted into the CFA/I operon, either replacing (hybrid I) or being added to the major CFA/I subunit-encoding cfaB gene (hybrid II). Using specific monoclonal antibodies against the major subunits of CFA/I and CS2, high levels of surface expression of both fimbrial subunits were shown in E. coli carrying the hybrid II operon. Oral immunization of mice with formalin-killed bacteria expressing hybrid II fimbriae induced strong CFA/I- and CS2-specific serum IgG + IgM and fecal IgA antibody responses, which were higher than those achieved by similar immunization with the reference strains. Bacteria expressing hybrid fimbriae are potential candidate strains in an oral-killed CF-ETEC vaccine, and the approach represents an attractive and novel means of producing a broad-spectrum ETEC vaccine.lld:pubmed
pubmed-article:20405124pubmed:languageenglld:pubmed
pubmed-article:20405124pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20405124pubmed:citationSubsetIMlld:pubmed
pubmed-article:20405124pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20405124pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20405124pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20405124pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20405124pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20405124pubmed:statusMEDLINElld:pubmed
pubmed-article:20405124pubmed:monthJullld:pubmed
pubmed-article:20405124pubmed:issn1432-0614lld:pubmed
pubmed-article:20405124pubmed:authorpubmed-author:SvennerholmAn...lld:pubmed
pubmed-article:20405124pubmed:authorpubmed-author:HolmgrenJanJlld:pubmed
pubmed-article:20405124pubmed:authorpubmed-author:LebensMichael...lld:pubmed
pubmed-article:20405124pubmed:authorpubmed-author:TobiasJoshuaJlld:pubmed
pubmed-article:20405124pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20405124pubmed:volume87lld:pubmed
pubmed-article:20405124pubmed:ownerNLMlld:pubmed
pubmed-article:20405124pubmed:authorsCompleteYlld:pubmed
pubmed-article:20405124pubmed:pagination1355-65lld:pubmed
pubmed-article:20405124pubmed:meshHeadingpubmed-meshheading:20405124...lld:pubmed
pubmed-article:20405124pubmed:meshHeadingpubmed-meshheading:20405124...lld:pubmed
pubmed-article:20405124pubmed:meshHeadingpubmed-meshheading:20405124...lld:pubmed
pubmed-article:20405124pubmed:meshHeadingpubmed-meshheading:20405124...lld:pubmed
pubmed-article:20405124pubmed:meshHeadingpubmed-meshheading:20405124...lld:pubmed
pubmed-article:20405124pubmed:meshHeadingpubmed-meshheading:20405124...lld:pubmed
pubmed-article:20405124pubmed:meshHeadingpubmed-meshheading:20405124...lld:pubmed
pubmed-article:20405124pubmed:meshHeadingpubmed-meshheading:20405124...lld:pubmed
pubmed-article:20405124pubmed:meshHeadingpubmed-meshheading:20405124...lld:pubmed
pubmed-article:20405124pubmed:meshHeadingpubmed-meshheading:20405124...lld:pubmed
pubmed-article:20405124pubmed:meshHeadingpubmed-meshheading:20405124...lld:pubmed
pubmed-article:20405124pubmed:meshHeadingpubmed-meshheading:20405124...lld:pubmed
pubmed-article:20405124pubmed:meshHeadingpubmed-meshheading:20405124...lld:pubmed
pubmed-article:20405124pubmed:meshHeadingpubmed-meshheading:20405124...lld:pubmed
pubmed-article:20405124pubmed:meshHeadingpubmed-meshheading:20405124...lld:pubmed
pubmed-article:20405124pubmed:year2010lld:pubmed
pubmed-article:20405124pubmed:articleTitleConstruction and expression of immunogenic hybrid enterotoxigenic Escherichia coli CFA/I and CS2 colonization fimbriae for use in vaccines.lld:pubmed
pubmed-article:20405124pubmed:affiliationUniversity of Gothenburg Vaccine Research Institute (GUVAX), 40530 Gothenburg, Sweden., Joshua.Tobias@microbio.gu.selld:pubmed
pubmed-article:20405124pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20405124pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed